Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins

References

• Junko E, Masahiro N, Satofumi M, Nobutaka U. Influence of mosapride citrate on gastric motility and autonomic nervous function: Evaluation by spectral analyses of heart rate and blood pressure variabilities, and by electrogastrography. J Gastroenterol 2002;37:888–895.
   PubMed Web of Science ®Google Scholar
• Liu Z, Sakakibara R., Odaka T. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov Disord 2005;20:680–686.
   PubMed Web of Science ®Google Scholar
• Futagami S, Iwakiri K, Shindo T, Kawagoe T, Horie A, Shimpuku M. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol 2010;45:413–421.
   PubMed Web of Science ®Google Scholar
• Kim H, Choi E. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea pig in vitro. Neurogastroenterol Motil 2008;20:169–176.
   PubMed Web of Science ®Google Scholar
• Sun X, Niu L, Li X, Lu X, Li F. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring opened mosapride by UPLC–ESI-MS/MS. J Pharm Biomed Anal 2009;50:27–34.
   PubMed Web of Science ®Google Scholar
• Kato S, Morie T, Kon T, Yoshida N, Karasawa T, Matsumoto J. Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N- [[4-(4-fluorobenzyl)-2-morpholinyl] methyl] benzamide citrate (AS-4370) and related compounds. J Med Chem 1991;34:616–624.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Byskov S, Brewster ME, Konrádsdóttir F. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 2007;96:2532–2546.
   PubMed Web of Science ®Google Scholar
• Derle D, Boddu SHS, Mager M. Studies on the preparation, characterization and solubility of β-cyclodextrin-starnidazole 7 inclusion complexes. Indian J Pharma Edu Res 2006;40:232–236.
   Google Scholar
• Govindrajan R, Nagarsenker MS. Influence of preparation methodology on solid state properties of an acidic drug-cyclodextrin system. J Pharmcol 2004;56:725–733.
   PubMed Web of Science ®Google Scholar
• Govindrajan R, Nagarsenker MS. Formulation studies and in vivo evaluation of a flurbiprofen-hydroxypropyl β-cyclodextrin system. Pharmaceut Dev Tech 2005;1:105–114.
   Google Scholar
• Baboota S, Dhariwal M, Kohli K. Physicochemical characterization, in vitro dissolution behavior and phamacodynamic studies of refecoxib cyclodextrin inclusion compound. Preparation and properties of refecoxib hydroxypropyl β-cyclodextrin inclusion complex. AAPS Pharma Sci Tech 2005;6:83–90.
   PubMed Web of Science ®Google Scholar
• Baboota S, Agrawal SP. Inclusion complexation of meloxicam with β-cyclodextrin. Indian J Pharma Sci 2002;64:408–411.
   Google Scholar
• Longxiao L, Suyan Z. Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl β-cyclodextrin. J Pharm Biomedical Anal 2006;40:122–127.
   PubMed Web of Science ®Google Scholar
• Ning L, Yun-Hui ZYN Wu, Xiao-Li X, Ya-Hui Z. Inclusion complex of trimethoprin with β-cyclodextrin. J Pharm Biomedical Anal 2005;39:824–829.
   PubMed Web of Science ®Google Scholar
• Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes: A review. J Pharm Sci Tech 2010;2:171–183.
   Google Scholar
• Rao VM, Haslam JL, Stella VJ. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxyl propyl methyl cellulose matrix tablets using SBE-β-cyclodextrin as a solubilizing agent. J Pharm Sci 2001;90:807–816.
   PubMed Web of Science ®Google Scholar
• Mosher G, Thompson DO. (2002). Complexation and cyclodextrins. In: Swarbrick J, Boylan JC. eds Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, 531–558.
   Google Scholar
• Higuchi T, Connors KA. (1965). Phase solubility techniques. In: Reilly CN. ed Advances in Analytical and Chemistry Instrumentation, Vol. 4. New York: Wiley Interscience, 117–212.
   Google Scholar
• Loftsson T, Matthíasson K, Másson M. The effects of organic salts on the cyclodextrin solubilization of drugs. Int J Pharm 2003;262:101–107.
   PubMed Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1–11.
   PubMed Web of Science ®Google Scholar
• Jain NK. Progress in controlled and novel drug delivery system. Cyclodextrin Based Drug Del Sys, 2004;1:384–400.
   Google Scholar
• Erden N, Celebi N. A study of the inclusion complex of naproxen with β-cyclodextrin. Int J Pharma 1988;48:83–89.
   Web of Science ®Google Scholar
• Derle D, Boddu SHS, Magar M. Studies on the preparation, characterization and solubility of betacyclodextrin satranidazole inclusion complexes. Indian J Pharm Educ Res 2006;40:232–236.
   Google Scholar
• Ribeiro LSS, Ferreira DC, Veiga FJB. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci 2003;20:253–266.
   PubMed Web of Science ®Google Scholar
• Williams RO, Mahaguna V, Sriwongjanya M. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm 1998;46:355–360.
   PubMed Web of Science ®Google Scholar
• Sauceau M, Rodier E, Fages J. Preparation of inclusion complex of piroxicam with cyclodextrin by using supercritical carbon dioxide. J Supercrit Fluids 2008;47:326–332.
   Web of Science ®Google Scholar
• Cabral Marques H, Hadgraft J, Kllaway I. Studies of cyclodextrin inclusion complexes. I. The Salbutamol cyclodextrin complex as studied by phase solubility and DSC. Int J Pharm 1990;63:259–266.
   Web of Science ®Google Scholar
• Ning L, Zhang YH, Wu Ya-Nan Xiong, XL, Zhang YH. Inclusion complex of trimethoprim with β-cyclodextrin. J Pharm Biomed Anal 2005;39:824–829.
   PubMed Web of Science ®Google Scholar
• Mura P, Adragna E, Rabasco AM, Moyano JR, Pérez-Martìnez JI, Arias MJ et al. Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev Ind Pharm 1999;25:279–287.
   PubMed Web of Science ®Google Scholar
• Ficarra R, Ficarra P, Di Bella MR, Raneri D, Tommasini S, Calabrò, ML et al. Study on the inclusion complex of atenolol with β-cyclodextrin. J Pharm Biomed Anal 2000;23:231–236.
   PubMed Web of Science ®Google Scholar
• Moyano JR, Gines JM, Arias MJ, Rabasco AM. Study of the dissolution characteristics of oxazepam via complexation with β-cyclodextrin. Int J Pharm 1995;114:95–102.
   Web of Science ®Google Scholar
• Dollo G, Corre P, Chollet M, Chevanne F, Bertault M, Burgot JL et al. Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J Pharm Sci 1999;88:889–895.
   PubMed Web of Science ®Google Scholar
• Betageri GV, Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm 1995;126:155–160.
   Web of Science ®Google Scholar